Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
Clinical trial NCT05338190 · RECRUITING
Trial details
- NCT number
- NCT05338190
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-14
- Primary completion
- 2026-11-14
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.